Chemical Variability Is the Hidden Determinant of Botanical Insecticide Reproducibility, Environmental Safety, and Field-Level Performance

INTRODUCTION

Botanical insecticides occupy an important but unsettled position between traditional plant use, natural-product discovery, formulation science, and operational pest management. Their attraction arises from extensive phytochemical diversity, multiple potential modes of action, renewable biological sources, and the possibility of developing products that complement existing control strategies. These advantages, however, are often discussed at the level of a plant species, extract category, or dominant compound, even though the entity delivered to an insect, crop, worker, or non-target organism is a chemically and physically specific product. Botanical insecticides can provide useful pest-management functions, but their promise depends on replacing identity-based assumptions with chemically and operationally defined products [1]. The central scientific problem is therefore not simply whether a plant preparation can produce biological activity. It is whether the material can be defined, reproduced, formulated, stored, delivered, and evaluated with sufficient consistency for its efficacy and safety claims to remain interpretable across batches and use conditions.

Discovery-oriented studies commonly begin with laboratory mortality, repellency, feeding inhibition, developmental disruption, or another target-organism endpoint. These experiments are valuable for identifying biological potential, but they rarely resolve whether the same chemical entity can be produced repeatedly or whether its activity will persist after formulation, storage, dilution, application, and environmental exposure. Laboratory activity is therefore only the beginning of product development, because formulation, persistence, application context, and farm-level performance remain separate evidentiary questions [2]. A botanical preparation that performs strongly in a controlled assay may lose volatile constituents, separate during storage, deposit unevenly, degrade rapidly, injure the treated crop, or expose beneficial organisms through routes absent from the discovery experiment. Conversely, a preparation with moderate acute toxicity may provide useful crop protection through repellency, feeding deterrence, developmental effects, or repeated low-intensity exposure. Laboratory potency, product performance, and operational effectiveness must consequently remain analytically distinct.

A further difficulty is that evidence is accumulated across non-equivalent materials and methods. Studies may use different plant organs, accessions, harvest seasons, drying conditions, extraction solvents, concentration units, exposure routes, target stages, observation periods, and endpoint definitions while applying the same species or extract label. The evidence base also contains recurrent taxonomic, methodological, and reporting biases that can conceal product-level heterogeneity and overstate generalizability [3]. A pooled category such as “essential oils,” for example, may include chemically distinct mixtures delivered by fumigation, contact exposure, treated surfaces, emulsions, or nanocarriers. Apparent disagreement among studies may therefore reflect genuine biological heterogeneity, uncontrolled chemical variation, exposure differences, or incompatible outcome measures rather than simple experimental error. Meaningful synthesis requires the tested entity and its context to be reconstructed before results are compared.

This article addresses that gap by treating chemical variability as a product-development determinant generated across the complete botanical-insecticide chain. Its scope extends from botanical provenance and chemotype through harvest, processing, extraction, analytical characterization, formulation, degradation, environmental exposure, reproducibility, safety, and field-level performance. The central argument is that standardization cannot be reduced to taxonomic authentication, a dominant-marker assay, a chromatographic fingerprint, or a single potency test. It must connect controlled inputs and processes to measured chemical attributes, formulation behavior, delivered exposure, target performance, and relevant safety outcomes. The proposed contribution is an original scholarly organization of these relations rather than a validated universal standard. Its purpose is to identify the distinctions, decision points, failure modes, and validation requirements needed to transform a biologically active botanical material into a chemically interpretable and prospectively testable product class.

Sources of chemical variability in botanical materials

Chemical variability begins before extraction or bioassay and may be embedded in the source material through taxonomy, accession, genotype, cultivation, collection, phenology, geography, and supply-chain history. A reproducible botanical product begins with authenticated provenance and a controlled supply chain, because local use records do not by themselves define a chemically equivalent material [4]. Ethnobotanical knowledge can identify useful species and preparation traditions, but vernacular identity and historical efficacy cannot establish that material collected from different regions, populations, or production systems has the same metabolite distribution. Source qualification therefore requires taxonomic authentication, plant-part definition, voucher or reference material, accession traceability where relevant, and documentation of cultivation or collection conditions. These controls establish provenance, not chemical equivalence; the chemical output of each qualified source must still be measured.

Within a single named species, essential-oil profiles and activity can vary materially among sources, demonstrating that species identity is not a chemical-equivalence criterion [5]. Variation may involve the presence or absence of constituents, shifts in the ratios among major compounds, changes in low-abundance metabolites, or differences in total recoverable oil or extract. Some compositional differences may alter penetration, volatility, target binding, mixture interactions, formulation compatibility, or degradation behavior. However, a correlation between a profile and an insecticidal response does not establish that the most abundant constituent caused the observed effect. Covarying compounds, extraction yield, exposure conditions, or assay sensitivity may provide competing explanations. Chemical markers should therefore be treated as provisional indicators until they demonstrate predictive relevance across independent batches and target-specific assays.

Preparation and environmental history further determine which chemical material reaches extraction. Preparation method is itself a source of chemical variability, and incomplete descriptions of plant state, solvent, ratio, duration, filtration, and dose prevent faithful replication [6]. Drying temperature, light, oxygen, moisture, storage duration, milling, transport, and contamination can alter volatile and non-volatile constituents before the formal extraction step begins. Geographic location, accession, and season can shift the composition of harvested botanical material even before extraction begins [7]. These influences may interact rather than operate independently: an accession may respond differently across seasons, while post-harvest processing may amplify or obscure source-related variation. The appropriate development response is not to presume that one favorable collection defines the species, but to specify a source-and-process envelope and verify each production lot against measured chemical attributes.

The evidence dimensions and interpretive boundaries for sources of chemical variability in botanical materials are summarized in Table 1.

Table 1. Sources of Chemical Variability in Botanical Materials: Chemical Identity, Mechanism, Standardization, Formulation, Safety, Resistance, and Translation Requirements

Chemotypes, harvest conditions, and plant processing

Chemotype classification is often proposed as a practical bridge between botanical identity and chemical specification. It can reduce heterogeneity by separating populations or accessions with recurrent compositional patterns, but it does not freeze constituent concentrations within a class. Chemotype classification narrows, but does not eliminate, within-source variability because constituent abundance can continue to shift across seasonal harvests [8]. A useful chemotype designation therefore requires replicated classification across locations, seasons, and production lots rather than assignment from one sample or one dominant peak. It should also be connected to the intended biological function. A chemically stable class may still lack predictive value if the distinguishing markers do not explain or forecast target activity, formulation behavior, degradation, or safety.

The convenience of a dominant chemical marker creates a particular standardization risk. A dominant constituent may be analytically convenient without being biologically equivalent to the whole oil, so a single-marker specification requires target-specific validation [9]. Whole mixtures can produce target-dependent effects that are not reproduced by the isolated major component, because minor constituents may alter penetration, volatility, metabolism, receptor interactions, or the effective ratio among active components. The opposite is also possible: a dominant constituent may account for much of the observed activity in one assay but not in another. Standardization should consequently combine marker content with a broader fingerprint and a relevant biological assay unless prospective evidence demonstrates that the marker reliably predicts whole-product performance across representative and edge-of-specification batches.

Harvest and post-harvest controls must also be interpreted in relation to the use environment and endpoint. The same applied material can produce different outcomes under different temperatures, showing that a batch specification cannot substitute for an exposure-context specification [10]. Temperature can influence volatilization, persistence, penetration, insect physiology, and effective exposure duration without changing the nominal dose. Processing introduces additional variability through drying, storage, milling, oxidation, moisture, light, and hold time. Chemical characterization must be paired with endpoint-specific testing because toxicity, repellency, and other functions are not interchangeable measures of performance [11]. A product that meets a mortality specification may not meet a repellency, ovicidal, crop-protection, or residual-performance specification. Source qualification, harvest envelopes, controlled processing, chemical release tests, and endpoint definitions must therefore be designed as connected controls rather than independent labels.

Extraction and analytical characterization

Extraction is the transition at which variable botanical material becomes a defined oil, fraction, crude extract, or purified product. It should not be treated as a neutral laboratory preparation step. Extraction should be treated as a controlled manufacturing operation because it determines which chemical fraction enters all subsequent characterization and efficacy tests [12]. Solvent polarity, plant-to-solvent ratio, particle size, temperature, pressure, duration, mixing, distillation conditions, and separation procedures can change recovery, transform unstable constituents, or create materially different products. Reproducibility therefore requires specified critical process parameters, mass balance, yield, complete chemical profiling, impurity assessment, and retained samples where feasible. Scale-up must be assessed separately because equipment geometry, heat transfer, solvent recovery, residence time, and separation efficiency may change the product even when the nominal procedure remains similar.

Analytical characterization must be matched to the entity being evaluated. For formulated botanicals, analytical characterization must include both the chemical payload and the delivery system because droplet or particle properties can change release and exposure [13]. Chemical identity, marker content, fingerprint similarity, impurities, degradation products, carrier composition, particle or droplet distribution, encapsulation, interfacial properties, and release behavior answer different questions. No single measurement can establish all of them. Solvent and extraction design can change both the recovered chemical profile and the apparent spectrum of activity, so extraction equivalence must be demonstrated rather than presumed [14]. Extracts prepared by materially different processes should be classified as separate product entities unless bridging studies demonstrate comparable chemistry, biological performance, formulation behavior, and safety.

The principal interpretive boundary is the difference between describing a batch and standardizing a product. A credible specification should connect an analytical fingerprint to a defined biological assay, while avoiding the inference that either one alone proves batch standardization [15]. A chromatogram can reveal identity and variation, but standardization also requires validated methods, representative batch history, prespecified acceptance criteria, sampling rules, measurement uncertainty, deviation investigation, and evidence that accepted variation remains compatible with relevant potency and safety outcomes. Likewise, a repeatable bioassay can indicate biological consistency without identifying chemical drift or explaining a future failure. Analytical and biological methods should therefore operate as complementary components of an assay-linked specification. The required acceptance region must remain product-, target-, formulation-, and endpoint-specific, and its predictive value must be established prospectively rather than assumed from retrospective agreement.

Formulation, degradation, and environmental exposure

Formulation is the point at which a chemically characterized botanical payload becomes a finished delivery system, and the transformation can change both biological performance and environmental behavior. Formulation is not merely a convenience layer: it can alter degradation, persistence, deposition, release, and the environmental compartments that receive the active material [16]. Emulsifiers, encapsulating matrices, carriers, interfacial properties, droplet or particle distributions, viscosity, adhesion, and release kinetics influence how much material reaches the target, how long it remains available, and which non-target receptors are exposed. A finished product must therefore be identified by the botanical payload and its qualified chemical range together with its formulation composition, physical state, storage condition, container, dilution procedure, application method, and intended exposure envelope. Greater laboratory potency after formulation may represent improved dispersion or exposure rather than increased intrinsic toxicity.

Once an oil is converted into a nanoemulsion, the product is no longer defined by the oil alone because the interfacial system and droplet properties become determinants of exposure and activity [17]. Formulation development must consequently evaluate chemical and physical stability as related but non-equivalent properties. Oxidation, hydrolysis, volatilization, constituent redistribution, aggregation, phase separation, or carrier degradation can change the delivered dose even when the product retains an acceptable appearance. Formulation stability and target toxicity are complementary outcomes: neither can be used as a proxy for the other, and both require prespecified acceptance criteria [18]. Shelf-life and in-use specifications should therefore be supported by stability-indicating chemical methods, appropriate physical measurements, release or deposition assessment, and a relevant potency assay. A formulation tested with one chemically favorable payload lot cannot be presumed robust to the full accepted range of botanical variability.

Environmental exposure extends the standardization problem beyond the container. Application rate, spray quality, temperature, humidity, rainfall, ultraviolet radiation, crop surface, soil, water, air movement, pest location, and receptor behavior determine the dose that reaches target and non-target organisms. Hazard and exposure must remain separate: a laboratory hazard does not by itself quantify field risk, but missing exposure data cannot be interpreted as evidence of safety. A formulation that increases target activity may still fail product development if it creates unacceptable crop injury or other exposure-dependent harms [19]. Intended-use scenarios should therefore specify crop or storage system, application route, environmental conditions, relevant receptors, and plausible exposure pathways. Natural origin is not equivalent to predictable environmental exposure, and labels such as natural, green, or eco-friendly cannot replace product-specific evidence on residues, fate, crop compatibility, worker contact, beneficial organisms, and other relevant environmental compartments.

Reproducibility, safety, and performance consequences

Chemical variability is propagated rather than erased as botanical material moves from source qualification through extraction, characterization, formulation, storage, application, and environmental exposure. Variability at an upstream stage can be attenuated by effective controls, amplified by formulation or environment, or concealed when only one biological endpoint is measured. Field evidence can demonstrate crop protection, yield, and beneficial-arthropod outcomes that are invisible to laboratory mortality assays, although uncontrolled batch chemistry still limits reproducibility [20]. Reproducibility should therefore be evaluated as agreement among defined chemical products under specified exposure conditions, not merely as repeated mortality within one assay. It includes within-laboratory repeatability, between-batch comparability, interlaboratory reproducibility, stability over time, and performance across relevant environments.

Figure 1 traces sources of chemical variability from plant genetics and cultivation to extraction, formulation, and field exposure within the analytical logic developed in this section.

Alt text

A structured conceptual diagram that traces sources of chemical variability from plant genetics and cultivation to extraction, formulation, and field exposure, with labelled components, directional relations, contextual modifiers, uncertainty points, and a clear boundary between observed evidence and proposed synthesis.

The practical meaning of reproducibility depends on matching the chemical profile, exposure route, target stage, and endpoint. Reproducibility requires matching chemical profile, exposure route, target stage, and endpoint because essential-oil performance is not a product-invariant property [21]. A batch may be repeatable in a contact-mortality assay yet differ in repellency, fumigant action, residual persistence, ovicidal activity, or crop-system performance. Product comparisons should therefore retain batch identifiers, analytical results, formulation state, application conditions, target stage, exposure route, observation period, and endpoint definition. Common reference materials and predefined comparability criteria are needed to separate product drift from assay imprecision. One successful replication cannot establish broader reproducibility, and a statistically similar mean cannot demonstrate equivalence when chemically important variation or endpoint-specific failures remain unresolved.

Safety and field performance further expand the relevant outcome space. A botanical treatment can influence crop growth and yield through pathways not captured by insect mortality, so product performance must be evaluated as a crop-system outcome [22]. Such effects may represent pest suppression, altered feeding, physiological plant responses, formulation effects, or interactions that cannot be inferred from acute mortality alone. Natural origin and target efficacy do not establish environmental safety, as an effective botanical nanoformulation can still produce consequential pollinator toxicity [23]. Hazard findings must be connected to realistic exposure before field risk is inferred, but beneficial-organism survival in one field context likewise cannot be generalized to all formulations, rates, crops, seasons, or receptors. Reproducibility, efficacy, crop compatibility, selectivity, and environmental safety are therefore related product attributes that require separate evidence and an explicit intended-use context.

The evidence dimensions and interpretive boundaries for reproducibility safety and performance consequences are summarized in Table 2.

Table 2. Reproducibility, Safety, and Performance Consequences: Chemical Identity, Mechanism, Standardization, Formulation, Safety, Resistance, and Translation Requirements

Proposed standardization requirements

The proposed standardization structure treats botanical-insecticide development as a connected evidence chain rather than a collection of independent tests. A defensible standard must connect raw-material control, chemical specification, formulation performance, biological efficacy, and safety rather than treating them as independent checklists [24]. The first requirement is an explicit product-class definition that distinguishes raw powders, aqueous or solvent extracts, essential oils, purified constituents, analogues, emulsions, nanoformulations, and other materially different entities. Each class must be connected to an intended use, target, crop or storage setting, route, dose form, and exposure scenario. Botanical authentication and provenance then define the source, while chemotype, harvest, handling, and extraction controls constrain the chemical population entering manufacture. These upstream controls remain inputs; batch release must depend on measured product attributes.

The scarcity of dependable products relative to the number of biologically active candidates reflects failures distributed across the development chain. The small proportion of candidates that become dependable products reflects cumulative failures across standardization, formulation, evidence quality, safety, production, and governance rather than a simple shortage of active plants [25]. The proposed organization therefore links source qualification, processing and extraction parameters, orthogonal chemical methods, assay-linked specifications, formulation robustness, stability, exposure, crop safety, non-target assessment, and laboratory-to-field comparability. Decision outcomes should include pass, conditional pass, hold, fail, and requalification. A conditional pass would restrict interpretation to a stated source, formulation, target, or exposure boundary; a hold would require evidence capable of resolving uncertainty; and requalification would be triggered when changes to source, process, formulation, scale, packaging, or use conditions could invalidate earlier comparability.

A separate development pathway should be recognized for purified or structurally simplified natural-product leads. Purified or simplified natural-product leads offer a route to chemical definition, but they should not be treated as evidence that variable whole-botanical preparations have achieved batch equivalence [26]. Purification can improve identity, dosing, structure–activity analysis, and manufacturing control, yet it creates a different product from the source extract or oil and may alter efficacy, safety, environmental behavior, and resistance implications. The proposed standardization requirements are therefore product-class-specific and explicitly non-validated. They do not establish universal markers, numerical acceptance limits, regulatory sufficiency, or deployment readiness. Prospective multi-batch, multi-environment, and independently replicated studies are required to determine whether the proposed components measure distinct decision-relevant constructs and whether accepted chemical ranges predict formulation, efficacy, crop, and non-target outcomes.

The proposed components, evidence bases, boundary conditions, failure modes, and validation requirements are organized in Table 3.

Table 3. Proposed Standardization Requirements: Components, Evidence Basis, Relations, Boundary Conditions, Failure Modes, and Validation Requirements